Affinage

EXOSC7

Exosome complex component RRP42 · UniProt Q15024

Length
291 aa
Mass
31.8 kDa
Annotated
2026-06-09
24 papers in source corpus 11 papers cited in narrative 12 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 6/7 claims corpus-supported (86%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

EXOSC7 (hRrp42p) is a structural, catalytically inactive RNase PH-domain subunit of the RNA exosome, the conserved multi-subunit 3'→5' exoribonuclease complex required for processing of rRNA and other RNA substrates (PMID:9390555). Within the exosome core, EXOSC7 adopts an RNase PH fold but lacks intrinsic nuclease activity; it heterodimerizes with the catalytically active EXOSC4 (Rrp41) subunit and contributes to structuring the adjacent EXOSC4 active site, while three such heterodimers assemble into a hexameric ring (PMID:15951817). This ring forms a central channel that entraps RNA, recognizing the substrate backbone sequence-unspecifically and discriminating RNA from DNA via 2'-OH contacts, thereby providing the processivity that drives continuous 3'→5' phosphorolytic degradation as the RNA 3' end shuttles among the three active sites (PMID:16285928, PMID:26837575). EXOSC7 is also a defined component of the human exosome, where it directly interacts with the cap subunit hCsl4p (EXOSC1) to mediate cap-subunit association (PMID:11879549). In mammalian cells EXOSC7 is one of the earliest initiating subunits of exosome assembly, nucleating complex formation together with EXOSC2 and EXOSC4 and templating the ordered incorporation of barrel and cap subunits; unincorporated orphan EXOSC7 is cleared by the ubiquitin-proteasome system (PMID:39982806). Disease-associated patient variants disrupt EXOSC7 either by reducing protein stability or, for normally expressed variants, by directly impairing RNA exosome function, as shown by humanized yeast complementation (PMID:39982806). EXOSC7 is additionally an autoantigen of the PM/Scl complex frequently targeted in idiopathic inflammatory myopathy (PMID:11812149).

Mechanistic history

Synthesis pass · year-by-year structured walk · 5 steps
  1. 1997 High

    Established that the EXOSC7 ortholog Rrp42p is an essential subunit of the exosome, defining the complex as a 3'→5' exoribonuclease machine required for rRNA processing.

    Evidence Mass spectrometry-based complex purification, genetic depletion and in vitro exoribonuclease assays in yeast

    PMID:9390555

    Open questions at the time
    • Did not resolve whether Rrp42p itself is catalytic or structural
    • No atomic-resolution architecture
  2. 2001 Medium

    Identified human EXOSC7 as a bona fide exosome component and clinically relevant autoantigen of the PM/Scl complex, linking the human protein to autoimmune disease.

    Evidence ELISA and western blotting of recombinant hRrp42p against patient sera; recombinant-protein interaction assays

    PMID:11812149 PMID:11879549

    Open questions at the time
    • Autoantigenicity does not define molecular function
    • hCsl4p interaction shown in a single lab
  3. 2005 High

    Resolved that EXOSC7/Rrp42 is catalytically inactive and instead structures the active site of its heterodimer partner Rrp41 within a hexameric ring, distinguishing structural from catalytic subunits.

    Evidence X-ray crystallography of the archaeal Rrp41-Rrp42 core with structure-guided mutagenesis and in vitro RNase assays

    PMID:15951817 PMID:16285928

    Open questions at the time
    • Archaeal model; mammalian-specific contributions not directly tested
    • How the ring achieves processivity not yet defined
  4. 2008 High

    Defined the mechanistic basis of processivity, showing the hexameric ring channels and entraps RNA so the 3' end engages active sites continuously.

    Evidence High-resolution crystallography, methyl-TROSY NMR, and RNA degradation assays with pore and active-site mutants in archaeal exosomes

    PMID:17380186 PMID:18353775 PMID:26837575

    Open questions at the time
    • Substrate channeling characterized in archaeal complexes only
    • EXOSC7-specific residues mediating channeling not isolated in human complex
  5. 2025 Medium

    Placed EXOSC7 as an early assembly initiator of the mammalian exosome subject to proteasomal quality control, and connected patient variants to function via two distinct mechanisms.

    Evidence Inducible CRISPR/Cas9 KO in mouse ES cells, proteasome inhibition, mass spectrometry, and humanized yeast complementation of disease variants

    PMID:39982806

    Open questions at the time
    • Disease mechanism inferred from yeast, not patient cells
    • Specific RNA substrates affected by variants not mapped
    • Assembly hierarchy from a single lab/preprint

Open questions

Synthesis pass · forward-looking unresolved questions
  • How EXOSC7 contributes to substrate selection and processing of specific human RNA targets, and the in vivo consequences of its variants in patient tissues, remain open.
  • No EXOSC7-specific substrate repertoire defined in human cells
  • Nucleolar recruitment role inferred only at the complex level [#11]

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0003723 RNA binding 2 GO:0005198 structural molecule activity 1
Localization
GO:0005730 nucleolus 1
Pathway
R-HSA-8953854 Metabolism of RNA 2
Complex memberships
PM/Scl complexRNA exosome

Evidence

Reading pass · 12 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
1997 Rrp42p (yeast ortholog of EXOSC7) is an essential component of the yeast exosome, a multi-subunit 3'→5' exoribonuclease complex required for 3' processing of 5.8S rRNA. Rrp42p shares homology with bacterial RNase PH phosphorolytic ribonucleases. Mass spectrometry-based complex purification, genetic depletion, in vitro exoribonuclease assays Cell High 9390555
2002 Human hRrp42p (EXOSC7) is a genuine component of the human exosome complex. hCsl4p directly interacts with hRrp42p as demonstrated by mammalian two-hybrid and GST pull-down assays, and this interaction mediates hCsl4p association with the exosome in vivo. Co-immunoprecipitation, mammalian two-hybrid assay, GST pull-down Journal of molecular biology Medium 11812149
2001 Human hRrp42p (EXOSC7) is an autoantigenic component of the PM/Scl complex (human exosome), recognized by autoantibodies in patients with idiopathic inflammatory myopathy, and is one of the most frequently targeted exosome components by autoantibodies. ELISA and western blotting using affinity-purified recombinant hRrp42p protein with patient sera Arthritis research Medium 11879549
2005 In the archaeal exosome, the Rrp41-Rrp42 heterodimer forms a hexameric ring (three heterodimers). Rrp42 adopts the RNase PH fold but is catalytically inactive; it contributes to structuring the active site of the adjacent catalytic Rrp41 subunit. Structure-guided mutagenesis confirmed that catalytic activity resides exclusively in Rrp41. X-ray crystallography at 2.8 Å resolution, structure-guided mutagenesis, in vitro ribonuclease assay Nature structural & molecular biology High 15951817
2005 Crystal structures of the Rrp41-Rrp42 core bound to short single-stranded RNAs and ADP revealed: the RNA-binding cleft recognizes four nucleotides in a sequence-unspecific manner primarily via phosphate backbone interactions; 2'-OH specificity distinguishes RNA from DNA; structures of both bound substrate and cleaved product defined the catalytic mechanism of 3'→5' phosphorolytic activity. X-ray crystallography with RNA and ADP ligands Molecular cell High 16285928
2007 The nine-subunit archaeal exosome channels RNA through a central pore; RNA binds at the active site on one side and at the narrowest constriction of the central channel on the opposite side. This entrapment in the channel provides a mechanistic basis for processive degradation of extended RNAs and stalling at structured RNAs. X-ray crystallography at 1.6 Å (apo) and 2.3 Å (RNA-bound) resolution EMBO reports High 17380186
2008 Structural studies of the Pyrococcus abyssi RNase PH ring revealed that residues from all three Rrp41-Rrp42 heterodimers contact a single RNA molecule within the catalytic chamber, providing mechanistic evidence for the functional role of the ring assembly in RNA processivity. An ADP-bound structure demonstrated rearrangement at the N1 site, suggesting a mechanism for nucleoside diphosphate elimination after catalysis. High-resolution X-ray crystallography, RNA degradation assays with active-site mutants The Journal of biological chemistry High 18353775
2006 The catalytic activity of the archaeal exosome resides in the Rrp41-Rrp42 hexameric ring, which degrades RNA phosphorolytically. Rrp4 and Csl4 cap subunits do not exhibit hydrolytic RNase activity alone or in complex, but modulate exosome activity. Various reconstituted complexes of different compositions showed variations in RNase activity, indicating functional interdependence of subunits. Biochemical fractionation, reconstitution of defined subcomplexes, RNase activity assays with depleted extracts Molecular microbiology High 17078816
2016 The quaternary (hexameric barrel) structure of the archaeal Rrp41:Rrp42 exosome is required for efficient RNA degradation. The entrance pore of the barrel provides nM substrate affinity essential for processivity, preventing premature RNA release. NMR analysis showed the RNA 3' end remains flexible inside the lumen, jumping between three active sites; because jumping is much faster than cleavage, confinement within the lumen ensures continuous active-site engagement. Methyl TROSY NMR, in vitro RNA degradation assays, mutagenesis of pore residues Nucleic acids research High 26837575
2025 In mammalian cells, EXOSC7 is one of the earliest initiating subunits in RNA exosome assembly; along with EXOSC2 and EXOSC4, it initiates complex formation and facilitates incorporation of barrel and cap subunits in a defined hierarchical order. Orphan (unassembled) EXOSC7 is degraded via the ubiquitin-proteasome system. Disease-associated variants of EXOSC7 show functional defects in yeast complementation assays, with some variants causing reduced protein levels and others being expressed normally yet functionally defective. Inducible dual-guide CRISPR/Cas9 KO in mouse embryonic stem cells, humanized yeast complementation, proteasome inhibitor experiments, mass spectrometry bioRxivpreprint Medium 39982806
2025 Humanized yeast expressing human EXOSC7 in place of the yeast ortholog revealed that disease-associated patient variants of EXOSC7 cause functional defects. Some patient-derived EXOSC7 variants show reduced protein levels, while others are expressed normally but are functionally impaired, suggesting direct contribution of those residues to RNA exosome function rather than destabilization. Humanized yeast complementation (replacement of yeast Rrp42 with human EXOSC7), growth assays, protein level quantification G3 (Bethesda, Md.) Medium 39982806
2023 EXOSC7-containing exosome complex is recruited to a ZNF692-organized nucleolar hub specialized in 18S rRNA processing and 40S ribosomal subunit maturation in the granular component of the nucleolus. Co-immunoprecipitation, proximity labeling, fluorescence microscopy, KD with ribosome biogenesis functional readout Cell reports Low 37851577

Source papers

Stage 0 corpus · 24 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
1997 The exosome: a conserved eukaryotic RNA processing complex containing multiple 3'-->5' exoribonucleases. Cell 808 9390555
2005 The archaeal exosome core is a hexameric ring structure with three catalytic subunits. Nature structural & molecular biology 185 15951817
2003 An exosome-like complex in Sulfolobus solfataricus. EMBO reports 118 12947419
2005 Structural basis of 3' end RNA recognition and exoribonucleolytic cleavage by an exosome RNase PH core. Molecular cell 102 16285928
2007 RNA channelling by the archaeal exosome. EMBO reports 99 17380186
2001 Autoantibodies directed to novel components of the PM/Scl complex, the human exosome. Arthritis research 72 11879549
2008 Insights into the mechanism of progressive RNA degradation by the archaeal exosome. The Journal of biological chemistry 50 18353775
2006 Characterization of native and reconstituted exosome complexes from the hyperthermophilic archaeon Sulfolobus solfataricus. Molecular microbiology 46 17078816
2021 The plasma peptides of Alzheimer's disease. Clinical proteomics 33 34182925
2002 Protein-protein interactions of hCsl4p with other human exosome subunits. Journal of molecular biology 32 11812149
2014 Structure and function of the archaeal exosome. Wiley interdisciplinary reviews. RNA 30 24789718
2012 Heterogeneous complexes of the RNA exosome in Sulfolobus solfataricus. Biochimie 22 22503705
2010 The evolutionarily conserved subunits Rrp4 and Csl4 confer different substrate specificities to the archaeal exosome. FEBS letters 22 20488184
2022 The new landscape of differentially expression proteins in placenta tissues of gestational diabetes based on iTRAQ proteomics. Placenta 16 36473392
2019 The RNA degradation pathway is involved in PPARα-modulated anti-oral tumorigenesis. BioMedicine 15 31724941
2010 The archaeal exosome localizes to the membrane. FEBS letters 15 20488181
2016 The oligomeric architecture of the archaeal exosome is important for processive and efficient RNA degradation. Nucleic acids research 13 26837575
2023 ZNF692 organizes a hub specialized in 40S ribosomal subunit maturation enhancing translation in rapidly proliferating cells. Cell reports 10 37851577
2021 Identification of Dysregulated Mechanisms and Potential Biomarkers in Ischemic Stroke Onset. International journal of general medicine 8 34456585
2011 The archaeal exosome. Advances in experimental medicine and biology 7 21713675
2010 The archaeal exosome. Advances in experimental medicine and biology 5 21618872
2024 Characterization of RNA Processing Genes in Colon Cancer for Predicting Clinical Outcomes. Biomarker insights 1 39161926
2025 Humanized Saccharomyces cerevisiae provides a facile and effective tool to identify damaging human variants that cause exosomopathies. G3 (Bethesda, Md.) 0 39982806
2020 Enzymatic Analysis of Reconstituted Archaeal Exosomes. Methods in molecular biology (Clifton, N.J.) 0 31768972

Missed literature

Know a paper Affinage missed for EXOSC7? Flag it for the maintainers and the community.

No submissions yet.